Cover Image
市場調查報告書

幹細胞銀行的全球市場預測 2021年:臍帶血、臍帶組織、採取、分析、加工、保存

Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021

出版商 MarketsandMarkets 商品編碼 363615
出版日期 內容資訊 英文 121 Pages
訂單完成後即時交付
價格
Back to Top
幹細胞銀行的全球市場預測 2021年:臍帶血、臍帶組織、採取、分析、加工、保存 Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021
出版日期: 2016年07月18日 內容資訊: 英文 121 Pages
簡介

全球幹細胞銀行市場規模,預計從2016年到2021年以20.2%的年複合成長率擴大,從2016年的15億8,000萬美元到2021年達到39億6,000萬美元。臍帶血的保存及治療用途的幹細胞領域的進步成為促進該市場的成長的主要原因。

本報告提供全球幹細胞銀行市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 幹細胞銀行市場上富有魅力的市場機會

第5章 幹細胞銀行的全球市場:概要

  • 市場區隔
    • 各銀行類型
    • 各類服務
    • 各用途
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 機會
    • 課題

第6章 幹細胞銀行的全球市場:各銀行類型

  • 簡介
  • 臍帶血
  • 臍帶組織

第7章 幹細胞銀行的全球市場:各類服務

  • 簡介
  • 採取、搬運
  • 加工
  • 分析
  • 保存

第8章 幹細胞銀行的全球市場:各用途

  • 簡介
  • 腦性麻痺
  • 地中海型貧血
  • 白血病
  • 糖尿病
  • 自閉症
  • 其他

第9章 幹細胞銀行的全球市場:各地區

  • 簡介
  • 北美
    • 各國
    • 各類型
    • 各類服務
    • 各用途
  • 歐洲
  • APAC (亞太地區)
  • ROW (其他)

第10章 競爭情形

  • 企業佔有率分析
  • 新服務/產品銷售
  • M&A
  • 法規核准
  • 聯盟
  • 合資企業
  • 協定
  • 共同研究
  • 技術更新
  • 專利
  • 地區擴大
  • 其他

第11章 企業簡介

  • CBR SYSTEMS, INC.
  • CORDLIFE
  • CRYO-CELL
  • CRYO-SAVE AG (A GROUP OF ESPERITE)
  • LIFECELL
  • STEMCYTE
  • VIACORD
  • SMART CELLS INTERNATIONAL LTD.
  • CRYOVIVA INDIA
  • CORDVIDA
  • CHINA CORD BLOOD CORPORATION

第12章 附錄

目錄
Product Code: BT 4447

The global stem cell banking market is expected to reach USD 3.96 billion by 2021 from USD 1.58 billion in 2016, at a CAGR of 20.2% from 2016 to 2021. The storage services segment is expected to contribute the maximum share to the overall market in 2016. Advancements in cord blood preservation and research in the field of stem cells for use as therapeutics are major factors fueling the growth of this market.

Processing services to contribute largest share in the stem cell biobanking market

The processing services segment is estimated dominate the market, by service type, in 2016 and the forecast period. North America is the major market for this segment. The large share of the storage services segment can be attributed to the high cost of the technology and equipment required for the processing of cord blood and cord tissue, in turn increasing the per-year cost of maintenance of the sample units.

Earlier, semi-automated centrifuges, such as AXP AutoXpress from Thermogenesis and Compomat from Fresenius Kabi (India) were used to separate blood components. However, companies are now focusing on updating technology to deliver high-quality products. For instance, Cordlife (Singapore) used Sepax, a fully automated closed system, in 2013, which has now become an industry standard followed by companies globally. In all the cases, the buffy coat is stored in single compartment cryobags.

North America is the largest contributor to the global stem cell banking market, while Asia-Pacific is the fastest-growing market segment

The U.S. is the largest segment of the North American market. This market is witnessing a shift in the preference from public to private banks. Parents are increasingly looking to storing their children's cord blood and tissue in private banks because of the possibility that samples in public banks may be given to other people for transplants or to research organizations. In the Asia-Pacific, market growth will be driven by the rising number of newborns and the low prices of storage services.

The stem cell biobanking market includes over 500 companies and banks across the globe; this also serves to aid market growth. These players include StemCyte (U.S.), Cryo-Cell International (U.S.), ViaCord (U.S.), Cord Blood Registry (U.S.), Smart Cells (U.K.), Cryo-Save (Netherlands), Cryoviva (India), LifeCell (India), Cordlife (Singapore), Cordvida (Brazil), and China Cord Blood Corporation (China).

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-industry analysis (industry trends), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the stem cell biobanking market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on umbilical cord blood and tissue processing and storage offered by top players in the global stem cell biobanking market.
  • Product Development/Innovation: Detailed insights on the processing and storage of cord blood and cord tissue, and new developments in the stem cell biobanking market.
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for stem cell biobanking across regions.
  • Market Diversification: Exhaustive information about services offered by banking companies, untapped geographies, recent developments, and applications of the global stem cell biobanking market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the global stem cell biobanking market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVE OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED IN THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
    • 2.1.2. KEY DATA FROM PRIMARY SOURCES
      • 2.1.2.1. Breakdown of primary interviews
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS
    • 2.4.1. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE OPPORTUNITIES IN THE STEM CELL BANKING MARKET

5. MARKET OVERVIEW

  • 5.1. MARKET SEGMENTATION
    • 5.1.1. STEM CELL BANKING, BY BANK TYPE
    • 5.1.2. STEM CELL BANKING, BY SERVICE
    • 5.1.3. STEM CELL BANKING, BY APPLICATION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Easy extraction methods
      • 5.2.1.2. Rising number of newborns
      • 5.2.1.3. Growth in GDP, disposable income, and increased awareness of stem cell therapeutics
      • 5.2.1.4. Potential of stem cells in disease treatment
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High competition in the stem cell banking market
      • 5.2.2.2. High operating cost
      • 5.2.2.3. Lack of acceptance
      • 5.2.2.4. Changes in legal regulations
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Rising awareness about potential use of cord tissue
      • 5.2.3.2. Collaborations among cord blood banks
      • 5.2.3.3. The automation of procedures
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Entry barriers in the market

6. STEM CELL BANKING MARKET, BY BANK TYPE

  • 6.1. INTRODUCTION
  • 6.2. CORD BLOOD
  • 6.3. CORD TISSUE

7. STEM CELL BANKING MARKET, BY SERVICE

  • 7.1. INTRODUCTION
  • 7.2. COLLECTION & TRANSPORTATION
  • 7.3. PROCESSING
  • 7.4. ANALYSIS
  • 7.5. STORAGE

8. STEM CELL BANKING MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. CEREBRAL PALSY
  • 8.3. THALASSEMIA
  • 8.4. LEUKEMIA
  • 8.5. DIABETES
  • 8.6. AUTISM
  • 8.7. OTHERS

9. STEM CELL BANKING MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. NORTH AMERICA, BY COUNTRY
    • 9.2.2. NORTH AMERICA, BY TYPE
    • 9.2.3. NORTH AMERICA, BY SERVICE
    • 9.2.4. NORTH AMERICA, BY APPLICATION
  • 9.3. EUROPE
    • 9.3.1. EUROPE, BY COUNTRY
    • 9.3.2. EUROPE, BY TYPE
    • 9.3.3. EUROPE, BY SERVICE
    • 9.3.4. EUROPE, BY APPLICATION
  • 9.4. ASIA-PACIFIC
    • 9.4.1. ASIA-PACIFIC, BY COUNTRY
    • 9.4.2. ASIA-PACIFIC, BY TYPE
    • 9.4.3. ASIA-PACIFIC, BY SERVICE
    • 9.4.4. ASIA-PACIFIC, BY APPLICATION
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. REST OF THE WORLD, BY TYPE
    • 9.5.2. REST OF THE WORLD, BY SERVICE
    • 9.5.3. REST OF THE WORLD, BY APPLICATION

10. COMPETITIVE LANDSCAPE

  • 10.1. COMPANY SHARE ANALYSIS
  • 10.2. NEW SERVICE/PRODUCT LAUNCHES
  • 10.3. MERGERS & ACQUISITIONS
  • 10.4. REGULATORY APPROVALS
  • 10.5. PARTNERSHIPS
  • 10.6. JOINT VENTURE
  • 10.7. AGREEMENTS
  • 10.8. COLLABORATIONS
  • 10.9. TECHNOLOGICAL UPDATE
  • 10.10. PATENT
  • 10.11. GEOGRAPHICAL EXPANSION
  • 10.12. OTHERS

11. COMPANY PROFILE (Company at a Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MNM View)*

  • 11.1. CBR SYSTEMS, INC.
  • 11.2. CORDLIFE
  • 11.3. CRYO-CELL
  • 11.4. CRYO-SAVE AG (A GROUP OF ESPERITE)
  • 11.5. LIFECELL
  • 11.6. STEMCYTE
  • 11.7. VIACORD
  • 11.8. SMART CELLS INTERNATIONAL LTD.
  • 11.9. CRYOVIVA INDIA
  • 11.10. CORDVIDA
  • 11.11. CHINA CORD BLOOD CORPORATION

*Details on company at a glance, recent financials, Products offered, strategies & insights, & recent developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GLOBAL STEM CELL BANKING MARKET, BY BANK TYPE, 2014-2021 (UNITS)
  • TABLE 2: STEM CELL BANKING MARKET VOLUME, BY BANK TYPE, 2016 (%)
  • TABLE 3: STEM CELL BANKING MARKET, BY BANK TYPE, 2014-2021 (USD MILLION)
  • TABLE 4: STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2016 (%)
  • TABLE 5: CORD BLOOD STEM CELL BANKING MARKET, BY REGION, 2014-2021 (UNITS)
  • TABLE 6: CORD BLOOD STEM CELL BANKING MARKET VOLUME, BY REGION, 2016 (%)
  • TABLE 7: CORD BLOOD STEM CELL BANKING MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: CORD BLOOD STEM CELL BANKING MARKET VALUE, BY REGION, 2016 (%)
  • TABLE 9: GLOBAL CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET, BY REGION, 2014-2021 (UNITS)
  • TABLE 10: CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET VOLUME, BY REGION, 2016 (%)
  • TABLE 11: GLOBAL CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET VALUE, BY REGION, 2016 (%)
  • TABLE 13: STEM CELL BANKING MARKET, BY SERVICES, 2014-2021 (USD MILLION)
  • TABLE 14: STEM CELL BANKING MARKET VALUE, BY SERVICES, 2016 & 2021 (%)
  • TABLE 15: STEM CELL BANKING MARKET FOR COLLECTION & TRANSPORTATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: STEM CELL BANKING MARKET FOR PROCESSING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: STEM CELL BANKING MARKET FOR ANALYSIS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: STEM CELL BANKING MARKET FOR STORAGE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NUMBER OF SAMPLES USED FOR APPLICATION, 2014-2021 (UNITS)
  • TABLE 20: STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (UNITS)
  • TABLE 21: STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (%)
  • TABLE 22: NUMBER OF STEM CELL UNITS RELEASED FOR APPLICATION MARKET, BY REGION, 2014-2021 (UNITS)
  • TABLE 23: NUMBER OF CLINICAL TRIALS USING STEM CELLS FROM CORD BLOOD AND CORD TISSUE IN CEREBRAL PALSY TREATMENT FROM 2014-2016
  • TABLE 24: STEM CELL BANKING MARKET IN CEREBRAL PALSY, BY REGION, 2014-2021 (UNITS)
  • TABLE 25: STEM CELL BANKING MARKET IN THALASSEMIA, BY REGION, 2014-2021 (UNITS)
  • TABLE 26: STEM CELL BANKING MARKET IN LEUKEMIA, BY REGION, 2014-2021 (UNITS)
  • TABLE 27: STEM CELL BANKING MARKET IN ANEMIA, BY REGION, 2014-2021 (UNITS)
  • TABLE 28: STEM CELL BANKING MARKET IN DIABETES, BY REGION, 2014-2021 (UNITS)
  • TABLE 29: STEM CELL BANKING MARKET IN AUTISM, BY REGION, 2014-2021 (UNITS)
  • TABLE 30: STEM CELL BANKING MARKET IN OTHERS, BY REGION, 2014-2021 (UNITS)
  • TABLE 31: STEM CELL BANKING MARKET, OVERVIEW, 2014-2021
  • TABLE 32: STEM CELL BANKING MARKET, BY REGION, 2014-2021 (UNITS)
  • TABLE 33: STEM CELL BANKING MARKET VOLUME, BY REGION, 2014-2021 (%)
  • TABLE 34: STEM CELL BANKING MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: STEM CELL BANKING MARKET VALUE, BY REGION, 2014-2021 (%)
  • TABLE 36: NORTH AMERICA STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (UNITS)
  • TABLE 37: NORTH AMERICA STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: NORTH AMERICA STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (UNITS)
  • TABLE 39: NORTH AMERICA STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA STEM CELL BANKING MARKET, BY SERVICE, 2014 -2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA STEM CELL BANKING MARKET, USAGE, 2014-2021
  • TABLE 42: NORTH AMERICA STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (UNITS)
  • TABLE 43: EUROPE STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (UNITS)
  • TABLE 44: EUROPE STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (UNITS)
  • TABLE 46: EUROPE STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE STEM CELL BANKING MARKET, BY SERVICE, 2014 -2021 (USD MILLION)
  • TABLE 48: EUROPE STEM CELL BANKING MARKET, USAGE, 2014-2021
  • TABLE 49: EUROPE STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (UNITS)
  • TABLE 50: ASIA-PACIFIC STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (UNITS)
  • TABLE 51: ASIA-PACIFIC STEM CELL BANKING MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: ASIA-PACIFIC STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (UNITS)
  • TABLE 53: ASIA-PACIFIC STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: ASIA-PACIFIC STEM CELL BANKING MARKET, BY SERVICE, 2014 -2021 (USD MILLION)
  • TABLE 55: ASIA-PACIFIC STEM CELL BANKING MARKET, USAGE, 2014-2021
  • TABLE 56: ASIA-PACIFIC STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (UNITS)
  • TABLE 57: REST OF THE WORLD STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (UNITS)
  • TABLE 58: REST OF THE WORLD STEM CELL BANKING MARKET, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: REST OF THE WORLD STEM CELL BANKING MARKET, BY SERVICE, 2014 -2021 (USD MILLION)
  • TABLE 60: REST OF THE WORLD STEM CELL BANKING MARKET, USAGE, 2014-2021
  • TABLE 61: REST OF THE WORLD STEM CELL BANKING MARKET, BY APPLICATION, 2014-2021 (UNITS)
  • TABLE 62: STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS, 2015 (%)

LIST OF FIGURES

  • FIGURE 1: STEM CELL BANKING MARKET: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & REGION
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: GLOBAL STEM CELL BANKING MARKET TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 6: THE PROCESSING SERVICES SEGMENT EXPECTED TO LEAD THE STEM CELL BANKING MARKET IN 2016
  • FIGURE 7: ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 8: STEM CELL BANKING MARKET, BY BANK TYPE, 2016 & 2021 (UNITS)
  • FIGURE 9: STEM CELL BANKING MARKET, BY BANK TYPE, 2016 & 2021 (USD MILLION)
  • FIGURE 10: CORD BLOOD STEM CELL BANKING MARKET, BY REGION, 2016 & 2021 (UNITS)
  • FIGURE 11: CORD BLOOD STEM CELL BANKING MARKET, BY REGION, 2016 & 2021 (USD MILLION)
  • FIGURE 12: CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET, BY REGION, 2016 & 2021 (UNITS)
  • FIGURE 13: CORD BLOOD & CORD TISSUE STEM CELL BANKING MARKET, BY REGION, 2016 & 2021 (USD MILLION)
  • FIGURE 14: STEM CELL BANKING MARKET, BY SERVICES
  • FIGURE 15: PROCESSING SEGMENT EXPECTED TO CONTINUE LEADING THE STEM CELL BANKING MARKET DURING FORECAST PERIOD
  • FIGURE 16: STEM CELL BANKING MARKET FOR COLLECTION & TRANSPORTATION, BY REGION, 2016 & 2021 (USD MILLION)
  • FIGURE 17: PROCESSING IS EXPECTED TO BE THE LARGEST SEGMENT OF THE NORTH AMERICAN STEM CELL BANKING MARKET
  • FIGURE 18: STEM CELL BANKING MARKET FOR ANALYSIS, BY REGION, 2016 & 2021 (USD MILLION)
  • FIGURE 19: STEM CELL BANKING MARKET FOR STORAGE, BY REGION, 2016 & 2021, (USD MILLION)
  • FIGURE 20: LARGEST NUMBER OF STEM CELLS ARE EXPECTED TO BE UTILIZED TO TREAT LEUKEMIA BY 2021 GLOBALLY
  • FIGURE 21: NORTH AMERICA TO CONTINUE LEADING THE APPLICATION SEGMENT OF THE STEM CELL BANKING MARKET DURING FORECAST PERIOD
  • FIGURE 22: CEREBRAL PALSY IS EXPECTED TO USE THE LARGEST NUMBER OF STEM CELL UNITS IN 2016
  • FIGURE 23: NORTH AMERICA IS ESTIMATED TO LEAD THE STEM CELL BANKING MARKET IN THALASSEMIA IN 2016
  • FIGURE 24: LARGEST NUMBER OF STEM CELLS FROM CORD BLOOD TO BE CONSUMED FOR LEUKEMIA TREATMENT
  • FIGURE 25: STEM CELL BANKING MARKET IN ANEMIA, BY REGION, 2016 & 2021 (UNITS)
  • FIGURE 26: DIABETES IS EXPECTED TO BE THE FASTEST GROWING SEGMENT OF STEM CELL BANKING MARKET DURING FORECAST PERIOD
  • FIGURE 27: STEM CELL BANKING MARKET IN AUTISM, BY REGION, 2016 & 2021 (UNITS)
  • FIGURE 28: STEM CELL BANKING MARKET IN OTHERS, BY REGION, 2016 & 2021 (UNITS)
  • FIGURE 29: ASIA-PACIFIC IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 30: NORTH AMERICA WILL CONTINUE TO DOMINATE THE STEM CELL BANKING MARKET DURING FORECAST PERIOD
  • FIGURE 31: NORTH AMERICA STEM CELL BANKING MARKET SNAPSHOT
  • FIGURE 32: EUROPE STEM CELL BANKING MARKET SNAPSHOT
  • FIGURE 33: ASIA-PACIFIC STEM CELL BANKING MARKET SNAPSHOT
  • FIGURE 34: STEM CELL BANKING MARKET: COMPANY SHARE ANALYSIS, 2015 (%)
  • FIGURE 35: CBR SYSTEMS, INC.: BUSINESS OVERVIEW
  • FIGURE 36: CORDLIFE: BUSINESS OVERVIEW
  • FIGURE 37: CRYO-CELL: BUSINESS OVERVIEW
  • FIGURE 38: CRYO-SAVE AG (A GROUP OF ESPERITE): BUSINESS OVERVIEW
  • FIGURE 39: VIACORD: BUSINESS OVERVIEW
  • FIGURE 40: CHINA CORD BLOOD CORPORATION: BUSINESS OVERVIEW
Back to Top